KELSO PHARMA LIMITED
KELSO PHARMA LIMITED is a private limited company registered in the United Kingdom, under SC678102, incorporated on 20 October 2020. The company is currently active. Operates in the dormant company sector (SIC 99999). The company has been operating for 5 years. Registered office address: TD5 8HG Kelso, the United Kingdom. Directors include MR ANDREW FIRTH MCLEAN, DR HARRY THOMAS STRATFORD, and MR ALLAN MARK WATSON. Shareholders include DR HARRY THOMAS STRATFORD and MR ANDREW FIRTH MCLEAN, and 1 other. Associated with 8 related entities, including BUSTAN INVESTMENTS LIMITED, SF000906, and STRATFORD T&P LTD. No sanctions, PEP status, or adverse risk signals are currently on record. Data sourced from UK Companies House.
Official Identifiers
Registered Address
WOODEN HOUSE
,
TD5 8HG KELSO
the United Kingdom
Signal Intelligence
No sanctions, PEP status, or adverse risk signals are currently on record for this entity.
Key Management & Controllers
Associated Entities
Companies sharing one or more directors or officers with this entity.
Source Records (1)
| companieshouse | SC678102 | 2026-06-01 | open_in_new |